BioProgress Starts Patent Action Against Stanelco

Law360, New York (October 22, 2003, 12:00 AM EDT) -- BioProgress Technology Limited, a wholly owned subsidiary of U.K. medical capsule maker BioProgress plc, Tuesday commenced proceedings against Stanelco Fibre Optics Limited, over "key" patents and patent applications, BioProgress said in a statement.

The case concerns patents for processes for encapsulation by gelatin-free polymeric materials, invented by BioProgress Technology Limited in 1998, according BioProgress. BioProgress has asked the court to issue an order to have BioProgress registered as the rightful owner of the patents and patent applications in question.

Under its generic brand XGelTM, BioProgress has...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.